Other languages Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
21.39 ^USD	+1.18%		-3.26%	-26.01%

May. 03	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
May. 03	Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Year 2024	May. 03
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	Feb. 28
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels	Feb. 09
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing	Feb. 09
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting	Nov. 03
Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2023	Nov. 03
Insider Sell: Fulgent Genetics	23-08-30
Sector Update: Health Care Stocks Steady Premarket Friday	23-08-04
Fulgent Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04
Fulgent Genetics, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Full Year 2023	23-08-04
Fulgent Genetics, Inc. Announces Data from a Phase 1/1b Clinical Study of FID-007 in Treating Various Solid Tancers	23-06-05
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05
Fulgent Genetics, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Full Year 2023	23-05-05
Fulgent Genetics to Use Mission Bio's Single-Cell Sequencing Platform	23-04-11
Fulgent Genetics Swings to Loss in Q4 As Revenue Plunges; Issues Guidance	23-02-28
Fulgent Genetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Other languages

Filters